Unknown

Dataset Information

0

Immunobiology of cholangiocarcinoma.


ABSTRACT: Cholangiocarcinoma (CCA) represents a heterogeneous group of epithelial tumours that are classified according to anatomical location as intrahepatic (iCCA), perihilar (pCCA), or distal (dCCA). Although surgical resection and liver transplantation following neoadjuvant therapy are potentially curative options for a subset of patients with early-stage disease, the currently available medical therapies for CCA have limited efficacy. Immunotherapeutic strategies such as immune checkpoint blockade (ICB) harness the host immune system to unleash an effective and durable antitumour response in a subset of patients with a variety of malignancies. However, response to ICB monotherapy has been relatively disappointing in CCA. CCAs are desmoplastic tumours with an abundant tumour immune microenvironment (TIME) that contains immunosuppressive innate immune cells such as tumour-associated macrophages and myeloid-derived suppressor cells. A subset of CCAs may be classified as immune 'hot' tumours with a high density of CD8+ T cells and enhanced expression of immune checkpoint molecules. Immune 'hot' tumour types are associated with higher response rates to ICB. However, the suboptimal response rates to ICB monotherapy in human clinical trials of CCA imply that the preponderance of CCAs are immune 'cold' tumours with a non-T cell infiltrated TIME. An enhanced comprehension of the immunobiology of CCA, particularly the innate immune response to CCA, is essential in the effort to develop effective combination immunotherapeutic strategies that can target a larger subset of CCAs.

SUBMITTER: Loeuillard E 

PROVIDER: S-EPMC7001542 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immunobiology of cholangiocarcinoma.

Loeuillard Emilien E   Conboy Caitlin B CB   Gores Gregory J GJ   Rizvi Sumera S  

JHEP reports : innovation in hepatology 20190710 4


Cholangiocarcinoma (CCA) represents a heterogeneous group of epithelial tumours that are classified according to anatomical location as intrahepatic (iCCA), perihilar (pCCA), or distal (dCCA). Although surgical resection and liver transplantation following neoadjuvant therapy are potentially curative options for a subset of patients with early-stage disease, the currently available medical therapies for CCA have limited efficacy. Immunotherapeutic strategies such as immune checkpoint blockade (I  ...[more]

Similar Datasets

| S-EPMC7295915 | biostudies-literature
| S-EPMC6993120 | biostudies-literature
| S-EPMC2856445 | biostudies-literature
| S-EPMC4407497 | biostudies-literature
| S-EPMC6943879 | biostudies-literature
| S-EPMC8218816 | biostudies-literature
2015-11-07 | GSE74786 | GEO
| S-EPMC2758173 | biostudies-other
| S-EPMC4971374 | biostudies-literature
| S-EPMC6151075 | biostudies-literature